STOCK Men1tm1.2Zqw/Flmg
Status | Available to order |
EMMA ID | EM:09502 |
International strain name | STOCK Men1tm1.2Zqw/Flmg |
Alternative name | Men1floxed/floxed |
Strain type | Targeted Mutant Strains : Conditional mutation |
Allele/Transgene symbol | Men1tm1.2Zqw, |
Gene/Transgene symbol | Men1 |
Information from provider
Provider | Philippe Bertolino |
Provider affiliation | Cancer Research Center of Lyon |
Genetic information | Mice carrying the homozygous floxed Men1 allele. |
Phenotypic information | Homozygous:No phenotype has been observed.Heterozygous:No phenotype has been observed. |
References |
|
Homozygous fertile | yes |
Homozygous viable | yes |
Homozygous matings required | no |
Immunocompromised | no |
Information from EMMA
Archiving centre | B.S.R.C. Alexander Fleming, Vari, Greece |
Animals used for archiving | homozygous mixed 129, C57BL/6, wild-type C57BL/6J |
Stage of embryos | Morula |
Disease and phenotype information
Orphanet associated rare diseases, based on orthologous gene matching
- Pituitary gigantism / Orphanet_99725
- Familial isolated hyperparathyroidism / Orphanet_99879
- Multiple endocrine neoplasia type 1 / Orphanet_652
Literature references
- Genetic ablation of the tumor suppressor menin causes lethality at mid-gestation with defects in multiple organs.;Bertolino Philippe, Radovanovic Ivan, Casse Huguette, Aguzzi Adriano, Wang Zhao-Qi, Zhang Chang-Xian, ;2003;Mechanisms of development;120;549-60; 12782272
- Pancreatic beta-cell-specific ablation of the multiple endocrine neoplasia type 1 (MEN1) gene causes full penetrance of insulinoma development in mice.;Bertolino Philippe, Tong Wei-Min, Herrera Pedro Luis, Casse Huguette, Zhang Chang Xian, Wang Zhao-Qi, ;2003;Cancer research;63;4836-41; 12941803
INFRAFRONTIER® and European Mouse Mutant Archive - EMMA® are registered trademarks at the European Union Intellectual Property Office (EUIPO).